Why is Remedium Life falling/rising?

As of 24-Jul, Remedium Lifecare Ltd's stock price is currently at 1.22, reflecting an increase of 0.02 or 1.67%. The stock has shown a positive performance today, outperforming its sector by 3.85% and has been gaining for the last two days, resulting in a total return of 3.39% during this period. However, despite this recent uptick, the company faces significant challenges, including a high Debt to EBITDA ratio of -1.00 times, which indicates a low ability to service debt. The company has reported negative results for the last three consecutive quarters, with a drastic fall in profit before tax of -94.11% and negative net sales growth of -96.31%. These factors contribute to a poor long-term growth outlook and a risky trading environment for the stock.
In the broader market context, the stock has outperformed the Sensex in the short term, with a 1-week return of +1.67% compared to the benchmark's slight decline of -0.09%. However, over the longer term, the stock has underperformed significantly, with a year-to-date return of -65.87% against the Sensex's gain of +5.18%. This stark contrast highlights the stock's volatility and the challenges it faces in maintaining investor confidence, especially given its historical performance and ongoing financial difficulties.